The neuroendocrine and metabolic effects of oestrogens in healthy postmenopausal women and men the same age

Trial Profile

The neuroendocrine and metabolic effects of oestrogens in healthy postmenopausal women and men the same age

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Jun 2016

At a glance

  • Drugs Estradiol (Primary) ; Letrozole (Primary) ; Tamoxifen (Primary)
  • Indications Atrophic vaginitis; Breast cancer; Endometrial cancer; Menopausal syndrome; Postmenopausal osteoporosis; Vasomotor symptoms
  • Focus Pharmacodynamics
  • Most Recent Events

    • 08 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top